Free Cash Flow Yield Explained
Last verified: 2026-06-21
Free cash flow yield compares the cash a business produces to the price investors are paying for the business. It is a valuation lens, not a magic answer. Used correctly, it helps you separate headline growth from actual cash generation.
The simple formula
A common version is free cash flow / market capitalization = free cash flow yield. If a company produces $1 billion of free cash flow and has a $20 billion market value, the free cash flow yield is 5%. In plain English, investors are paying $20 billion for a business currently producing about $1 billion of annual free cash flow.
Why investors use it
Earnings can be affected by accounting assumptions. Revenue can grow while cash generation stays weak. Free cash flow yield forces the review back to cash after operating costs and capital spending. It can make an expensive-looking growth stock easier to analyze, or expose a cheap-looking stock that is cheap for a reason.
Enterprise value version
For companies with meaningful debt or cash, some investors compare free cash flow to enterprise value instead of market cap. Enterprise value adjusts for debt and cash, which can make comparisons cleaner. The key is consistency: do not compare one company using market cap and another using enterprise value without knowing why.
What can distort the number
Free cash flow can be temporarily boosted or hurt by working-capital timing, one-time capital spending, asset sales, acquisitions, or cyclical peaks. A single year can mislead. A better process reviews several years, margin direction, capital intensity, and balance-sheet flexibility.
A quick research workflow
Start with three questions: is free cash flow positive, is it stable or improving, and is the current valuation reasonable compared with the cash being produced? Then check debt, reinvestment needs, share count, and whether management is converting cash into durable business value.
How Bucko fits
Bucko can store a cash-flow research note with the formula, assumptions, multi-year observations, red flags, and next review date. The value is not predicting the future; the value is keeping the research process evidence-based and repeatable.